We are live on ! Find out more
Mariner

Mariner Portfolio holdings

AUM $85.7B
1-Year Est. Return 24.21%
This Fund
S&P 500
This Quarter Est. Return
+6.54%
1 Year Est. Return
+24.21%
3 Year Est. Return
+74.24%
5 Year Est. Return
+87.67%
10 Year Est. Return
+269.13%
AUM
$56.4B
AUM Growth
+$4.78B
Cap. Flow
+$1.89B
Cap. Flow %
3.35%
Top 10 Hldgs %
25.87%
Holding
3,434
New
281
Increased
1,727
Reduced
1,174
Closed
149

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$278M
2
NVDA icon
NVIDIA
NVDA
+$145M
3
TT icon
Trane Technologies
TT
+$95.8M
4
LULU icon
lululemon athletica
LULU
+$92.1M
5
TREE icon
LendingTree
TREE
+$83.6M

Sector Composition

Rank Sector Weight
1 Technology 19.45%
2 Financials 7.32%
3 Healthcare 5.85%
4 Consumer Discretionary 5.33%
5 Industrials 4.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SURG icon
3126
SurgePays
SURG
$6.05M
$79.9K ﹤0.01%
43,400
PACK icon
3127
Ranpak Holdings
PACK
$553M
$79.8K ﹤0.01%
12,225
+137
+1% +$943
NVTS icon
3128
Navitas Semiconductor
NVTS
$2.66B
$79.3K ﹤0.01%
32,364
+21,947
+211% +$71.3K
PGRE
3129
DELISTED
Paramount Group
PGRE
$79.3K ﹤0.01%
16,112
-896
-5% -$4.44K
TLRY icon
3130
Tilray
TLRY
$479M
$78.7K ﹤0.01%
4,471
+622
+16% +$11.2K
SHCR
3131
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$78.6K ﹤0.01%
55,380
-158
-0.3% -$219
PPT
3132
Franklin Premier Income Trust
PPT
$323M
$78.1K ﹤0.01%
20,928
-498
-2% -$1.82K
ORGN
3133
DELISTED
Origin Materials
ORGN
$76.7K ﹤0.01%
1,661
-103
-6% -$3.73K
BCRX icon
3134
BioCryst Pharmaceuticals
BCRX
$2.37B
$76.3K ﹤0.01%
+10,034
New +$76.3K
DDD icon
3135
3D Systems Corp
DDD
$420M
$76.3K ﹤0.01%
26,850
-11,924
-31% -$34.3K
STKL
3136
DELISTED
SunOpta
STKL
$75.8K ﹤0.01%
11,875
-1,900
-14% -$11.1K
NG icon
3137
NovaGold Resources
NG
$2.6B
$75.1K ﹤0.01%
18,270
+3,607
+25% +$15.3K
GALT icon
3138
Galectin Therapeutics
GALT
$229M
$73.1K ﹤0.01%
26,585
+109
+0.4% +$268
BBDO icon
3139
Banco Bradesco
BBDO
$33.9B
$72.8K ﹤0.01%
+29,729
New +$68.9K
EGY icon
3140
Vaalco Energy
EGY
$594M
$72.8K ﹤0.01%
12,688
-2,729
-18% -$17.2K
HIMX
3141
Himax Technologies
HIMX
$2.2B
$72.6K ﹤0.01%
13,195
+132
+1% +$836
TGB
3142
Trekor Metals
TGB
$2.56B
$71.7K ﹤0.01%
28,043
-5,340
-16% -$11.9K
BHR
3143
Braemar Hotels & Resorts
BHR
$153M
$70.8K ﹤0.01%
22,845
-216
-0.9% -$678
MDXG icon
3144
MiMedx Group
MDXG
$626M
$70.5K ﹤0.01%
11,930
-897
-7% -$5.94K
CGNT icon
3145
Cognyte Software
CGNT
$612M
$70.3K ﹤0.01%
10,357
-370
-3% -$2.7K
RUM icon
3146
RUM Group Inc
RUM
$1.57B
$70.1K ﹤0.01%
13,082
MOBX icon
3147
Mobix Labs
MOBX
$27.5M
$69.4K ﹤0.01%
6,545
HOUS
3148
DELISTED
Anywhere Real Estate
HOUS
$69K ﹤0.01%
+13,584
New +$63K
MJ icon
3149
Amplify Alternative Harvest ETF
MJ
$101M
$68.6K ﹤0.01%
1,727
-378
-18% -$15.4K
RKDA icon
3150
Arcadia Biosciences
RKDA
$1.4M
$68.3K ﹤0.01%
+25,000
New +$71.7K

Similar funds

Mariner's Q3 2024 Portfolio in Review

As of Q3 2024, Mariner held 3,434 positions worth $56.4B, up 9.3% from $51.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Mariner deployed $1.89B of net new capital in Q3 2024, opening 281 new positions and adding to 1,727 existing holdings. Its largest new stake was Fidelity Fundamental Large Cap Core ETF: 1,060,968 shares worth $48.4M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apollo Global Management, an estimated $216M trimmed.

  • Mariner's largest Q3 2024 buy was Fidelity Fundamental Large Cap Core ETF: 1,060,968 shares worth $48.4M.
  • Mariner added most to Microsoft in Q3 2024, an estimated $278M increase.
  • Mariner's biggest Q3 2024 reduction was Apollo Global Management, cutting an estimated $216M.
  • Mariner fully exited UFP Technologies in Q3 2024, selling an estimated $3.43M.
  • Mariner's ten largest holdings make up 26% of its $56.4B portfolio in Q3 2024.
  • Mariner opened 281 new positions and closed 149 in Q3 2024.
  • Mariner's portfolio value rose 9.3% quarter-over-quarter to $56.4B.

Based on Mariner's 13F filing for Q3 2024, filed 13 Nov 2024.